George from Saudi Arabia

Registered at the short selling broker Capital, 2 minutes ago.

» Try Capital you too
71.2% of retail investor accounts lose money when trading CFDs with Capital.
Don't show again

Ocugen Inc (OCGN) shares information

Ocugen Inc


24h Change

10.67 %

OCGN

Live rate: Market closed

Stock data per Monday 10 May, 2021

OCGN
NASDAQ CAPITAL MARKET
9.185
10.17
0.98 (+ 10.67%)
US Market is closed

Live Stock price in graph for Ocugen Inc (OCGN)

  • Latest Volume

    117,894,300 (-33.69 %)

  • Volume prev. day

    177,794,503

  • Avg. daily volume

    124,736,404

  • Market cap

    1,912,713,001

  • P/E ratio

    n/a

  • Today high

    n/a

  • Today low

    n/a

  • 52 week high

    18.77 USD

  • 52 week low

    0.17 USD

  • YTD Change

    + 412.58 %

Quick links

 

Latest news about Ocugen Inc

Below you can find the most recent news posts about Ocugen Inc, primarily from US and UK based news sources.

Ocugen Shares Sink Despite OCU200 Being Comparable To Aflibercept In Reducing Neovascularization, Damage To Retina In Animal Study

Thursday, 6 May 2021, 18:28:43
Ocugen Inc (NASDAQ: OCGN ) has announced the presentation of new preclinical data evaluating the efficacy of OCU200 in in-vitro and in-vivo models for ocular neovascular diseases. The data will be presented at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting. OCU200 is a biologic product candidate in preclinical … Full story available on Benzinga.com
— Benzinga


Ocugen Shares Gain After Its Partner's COVID-19 Vaccine Shows Effectiveness Against Multiple Variants

Monday, 3 May 2021, 14:07:31
Ocugen Inc (NASDAQ: OCGN ) has announced that in a new study , COVAXIN demonstrated potential effectiveness against the Brazil variant of SARS-CoV-2, B.1.128.2. The study was conducted at the Indian Council of Medical Research (ICMR)-National Institute of Virology. Ocugen is developing COVAXIN, Bharat Biotech's COVID-19 vaccine candidate, for the U.S. market. In the recently Full story available on Benzinga.com
— Benzinga


Cramer Weighs In On Coinbase, Kellogg And More

Thursday, 29 April 2021, 13:50:25
Jim Cramer said on CNBC's “Mad Money Lightning Round” that he has always felt that Ocugen Inc (NASDAQ: OCGN ) is a great spec, but it's a heavily shorted stock and he doesn't know what is going on between longs and shorts. Inovio Pharmaceuticals Inc (NASDAQ: INO ) is a speculative stock that … Full story available on Benzinga.com
— Benzinga


Why Ocugen Shares Skyrocketed Today

Friday, 23 April 2021, 03:58:10
Ocugen Inc (NASDAQ: OCGN ) shares soared 42.9% in the regular session and another 11% in the after-hours session on Thursday. What Happened: The shares surged following positive clinical data announced by a partner of Ocugen and a bullish stance taken by Roth Capital analyst Zegbeh Jallah who has a Buy rating on the stock and a 12-month price target of $10. Earlier, on Wednesday, Ocugen’s co-development partner Bharat Biotech said that the second interim analysis … Full story available on Benzinga.com
— Benzinga


Cramer Gives His Opinion On MP Materials And More

Wednesday, 7 April 2021, 13:37:37
On CNBC's “Mad Money Lightning Round,” Jim Cramer said Ocugen Inc (NASDAQ: OCGN ) is a good spec. Instead of … Full story available on Benzinga.com
— Benzinga


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have OCGN available or trade one of the many other CFD stocks they have.
Risk warning: 71.2% of retail investor accounts lose money when trading CFDs with Capital.